genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Cancer
The Life Oncolytic, with Stephen Russell
Synthetic Biology
Flush with Cash, Foresite Aims to Live Up to Its Name
OMICs
From Genomes to Drugs: An Interview with Vertex CSO David Altshuler
Gene Therapy
AI Gets Gene Therapy Over the Immunity Hump
OMICs
Immunai Expands from Observational to Functional Genomics
News
Bioprocessing
Gates Biomanufacturing Reaches Milestone
Bioprocessing
EV Biologics Approves Plan to Scale Up Exosome Drug Manufacture
Regenerative Medicine/Tissue Engineering
Researchers Pinpoint the Workings behind Liver Regeneration
OMICs
New Bone Cell Type Identified, Could Point to Drug Targets for…
OMICs
Large-Scale Biobank Study Links Primary Cilium to Diabetes, Kidney Disease, and…
Insights
All
Trends for 2021
Trends for 2020
A-Lists
Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020
Bioprocessing
COVID-19 Increasing Risk of Cyberattacks for Digital Biopharma
Bioprocessing
Case Study: How to Accelerate COVID-19 Vaccine Development
Bioprocessing
Flexibility is Key to Advances in Biomanufacturing
A-Lists
A-Lists
Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Bioprocessing
Gates Biomanufacturing Reaches Milestone
Bioprocessing
EV Biologics Approves Plan to Scale Up Exosome Drug Manufacture
Regenerative Medicine/Tissue Engineering
Researchers Pinpoint the Workings behind Liver Regeneration
OMICs
New Bone Cell Type Identified, Could Point to Drug Targets for…
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Topics
OMICs
OMICs
Comparative Genomic Hybridization
DNA
Epigenetics
Gene Expression
Gene Synthesis
Genetic Disorders
Genomics
Genotyping
Mass Spectrometry
Microarrays
Microbiome
PCR
Protein-Protein Interactions
Proteomics
RNA
Sequencing
Transcriptome
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
OMICs
Ancient Genes Return, Put Evolutionary Hypotheses to the Test
OMICs
Pfizer and DiaGenic Collaborate on Blood-Based Gene-Expression Signatures for Early AD
OMICs
BGI Offers $117.6M to Acquire Complete Genomics
OMICs
Microbiome Influenced by Genetic Differences in Immune System
OMICs
Big Data Screen Uncovers New Cancer Driver Genes
OMICs
DNA “Wormholes” Increase Cancer Risk
OMICs
Illumina’s Push to Democratize Genomics with the iSeq 100
OMICs
Chem Cocktail Improves Cardiac Scar Tissue Rehab
OMICs
Redosable Gene-Therapy Developer Generation Bio Wins $100M Series B Financing
OMICs
Intrexon Makes $11.63M Equity Payment in Ziopharm as Part of DNA-Based...
OMICs
Ziopharm Restructuring After Phase III Failure
OMICs
NY Genome Center Names President-Scientific Director
OMICs
Mom or Dad? DNA Study May Boost Personalized Medicine
OMICs
Bruker to Buy Certain Varian Chromatography Product Lines from Agilent
OMICs
BGI, University of Manchester Launch Synthetic Biology Collaboration
1
2
3
...
337
Page 1 of 337
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Partnership provides Ziopharm with rights to UltraVector platform and two clinical-stage oncology candidates.[ktsdesign-Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/UGENWebsitepicturesTopStoriesJan2011Jan7_2010_3986080_PurpleBlueDNAStripes_ZioPharmIntrexonSyntheticBioCollab3423572919-324x160.jpg "Intrexon Makes $11.63M Equity Payment in Ziopharm as Part of DNA-Based Anticancer Drug Deal")
